Deep deletions were significantly more prevalent in prostate cancer tissues (Figure 3b) compared to breast cancer tissues, where they were relatively rare and limited to ABCG2, ABCC4, ABCA2, ABCC2, and ABCC9 (Figures 3a and 4). This evidence concerns the gene ABCA2 and breast carcinoma.